Anxiolytic Drugs

Deidre M. Edwards; Kathryn L. Hale; Rachel E. Maddux; Mark Hyman Rapaport; Steven P. Roose

doi:10.1002/9780470515167.ch104

Anxiolytic Drugs

Deidre M. Edwards, Kathryn L. Hale, Rachel E. Maddux, Mark Hyman Rapaport, Steven P. Roose

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter provides a brief history of the evolution of medications used to treat anxiety and anxiety disorders, as described in the Diagnostics and Statistical Manual of Mental Disorders (DSM-IV-TR). We also summarize the efficacy and adverse effects data from clinical trials for these medications. Medication classes reviewed include antidepressants, benzodiazepines, beta-blockers, anticonvulsants, and antipsychotics. Treatment outcomes and clinical implications are reviewed for each of the individual medication classes.

Original language	English (US)
Title of host publication	Psychiatry
Subtitle of host publication	Third Edition
Publisher	John Wiley & Sons, Ltd.
Pages	2223-2253
Number of pages	31
Volume	2
ISBN (Print)	9780470065716
DOIs	https://doi.org/10.1002/9780470515167.ch104
State	Published - Aug 8 2008
Externally published	Yes

Keywords

Anxiety
Anxiolytic drugs
Generalized anxiety disorder
Obsessive-compulsive disorder
Panic disorder
Posttraumatic stress disorder
Social anxiety disorder

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/9780470515167.ch104

Cite this

@inbook{bac51cfc3b12432ba6332e27652a2bd9,

title = "Anxiolytic Drugs",

abstract = "This chapter provides a brief history of the evolution of medications used to treat anxiety and anxiety disorders, as described in the Diagnostics and Statistical Manual of Mental Disorders (DSM-IV-TR). We also summarize the efficacy and adverse effects data from clinical trials for these medications. Medication classes reviewed include antidepressants, benzodiazepines, beta-blockers, anticonvulsants, and antipsychotics. Treatment outcomes and clinical implications are reviewed for each of the individual medication classes.",

keywords = "Anxiety, Anxiolytic drugs, Generalized anxiety disorder, Obsessive-compulsive disorder, Panic disorder, Posttraumatic stress disorder, Social anxiety disorder",

author = "Edwards, {Deidre M.} and Hale, {Kathryn L.} and Maddux, {Rachel E.} and Rapaport, {Mark Hyman} and Roose, {Steven P.}",

year = "2008",

month = aug,

day = "8",

doi = "10.1002/9780470515167.ch104",

language = "English (US)",

isbn = "9780470065716",

volume = "2",

pages = "2223--2253",

booktitle = "Psychiatry",

publisher = "John Wiley & Sons, Ltd.",

}

TY - CHAP

T1 - Anxiolytic Drugs

AU - Edwards, Deidre M.

AU - Hale, Kathryn L.

AU - Maddux, Rachel E.

AU - Rapaport, Mark Hyman

AU - Roose, Steven P.

PY - 2008/8/8

Y1 - 2008/8/8

N2 - This chapter provides a brief history of the evolution of medications used to treat anxiety and anxiety disorders, as described in the Diagnostics and Statistical Manual of Mental Disorders (DSM-IV-TR). We also summarize the efficacy and adverse effects data from clinical trials for these medications. Medication classes reviewed include antidepressants, benzodiazepines, beta-blockers, anticonvulsants, and antipsychotics. Treatment outcomes and clinical implications are reviewed for each of the individual medication classes.

AB - This chapter provides a brief history of the evolution of medications used to treat anxiety and anxiety disorders, as described in the Diagnostics and Statistical Manual of Mental Disorders (DSM-IV-TR). We also summarize the efficacy and adverse effects data from clinical trials for these medications. Medication classes reviewed include antidepressants, benzodiazepines, beta-blockers, anticonvulsants, and antipsychotics. Treatment outcomes and clinical implications are reviewed for each of the individual medication classes.

KW - Anxiety

KW - Anxiolytic drugs

KW - Generalized anxiety disorder

KW - Obsessive-compulsive disorder

KW - Panic disorder

KW - Posttraumatic stress disorder

KW - Social anxiety disorder

UR - http://www.scopus.com/inward/record.url?scp=84889847428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889847428&partnerID=8YFLogxK

U2 - 10.1002/9780470515167.ch104

DO - 10.1002/9780470515167.ch104

M3 - Chapter

AN - SCOPUS:84889847428

SN - 9780470065716

VL - 2

SP - 2223

EP - 2253

BT - Psychiatry

PB - John Wiley & Sons, Ltd.

ER -

Anxiolytic Drugs

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this